Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial

NCT04414189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-12-22

No results posted yet for this study

Summary

This study will analyze HostDx Sepsis results from whole blood samples collected from patients with suspected sepsis or at risk for sepsis in the surgical ICU

Conditions

Interventions

DIAGNOSTIC_TEST

HostDx Sepsis

Blood collection for mRNA analysis

Sponsors & Collaborators

  • University of Florida

    collaborator OTHER
  • Inflammatix

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-07
Primary Completion
2021-07-21
Completion
2021-10-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04414189 on ClinicalTrials.gov